One trip on a psychedelic mushroom may leave a physical mark on the brain that lasts for weeks, researchers have found. The discovery helps explain how a single dose of psilocybin can produce lasting therapeutic relief.
A 2026 study reported that a single dose of psilocybin, the active compound in "magic mushrooms," produced measurable changes in brain activity and possible changes in brain structure that persisted for up to a month. Brain scans detected the shifts long after the immediate subjective "trip" had ended.
Most psychoactive substances wash out of the brain in hours. Psilocybin's effects on brain structure are unusual in their durability. Researchers believe the drug temporarily loosens the rigid, repetitive wiring that underlies depression and anxiety, allowing the brain to rewire itself into healthier patterns. If a single dose can initiate that reset, the clinical implications are enormous: one treatment, rather than daily medication for months.
The findings do not mean psilocybin should be taken recreationally to rewire the brain. Clinical psilocybin research is conducted under careful medical supervision, because the intensity of the experience and the resulting brain changes are powerful. Still, the 2026 result adds concrete biological evidence to a growing case: for a subset of patients struggling with treatment-resistant depression, a guided psychedelic experience may do lasting neurological work that conventional drugs cannot match.
This study fits a wider revival of psychedelic science. After decades on the sidelines, compounds like psilocybin, MDMA and LSD are back on the agenda of major drug regulators and academic labs worldwide. The question has shifted from "can it work?" to "exactly how does it work, and for whom?" and this month-long brain signature is one of the clearest answers yet.